They say to "follow the money," and I've made a career of it. As a market journalist, I believe opinions are cheap, but data is the only currency that counts. I'm your financial detective, digging ...

Non-communicable diseases such as cancer and cardiovascular disorders kill millions of people each year, with numbers increasing particularly in low- and middle-income countries. The IAEA has ...

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

GSK has become the latest drugmaker to run into difficulties in developing a drug targeting the immune checkpoint receptor TIM-3, after its cobolimab candidate flunked a phase 3 trial in lung cancer.

Build the skills, strategy and credibility to lead AI transformation AI is disrupting every sector, but most professionals lack the clarity and confidence to lead it. The LSE AI Leadership Accelerator ...